Literature DB >> 35852648

The Enlargement of Ablation Area by Electrolytic Irreversible Electroporation (E-IRE) Using Pulsed Field with Bias DC Field.

Yanpeng Lv1, Heqing Liu2, Zhikui Feng2, Jianhua Zhang2, Genyong Chen2, Chenguo Yao3.   

Abstract

Irreversible electroporation (IRE) by high-strength electric pulses is a biomedical technique that has been effectively used for minimally invasive tumor therapy while maintaining the functionality of adjacent important tissues, such as blood vessels and nerves. In general, pulse delivery using needle electrodes can create a reversible electroporation region beyond both the ablation area and the vicinity of the needle electrodes, limiting enlargement of the ablation area. Electrochemical therapy (EChT) can also be used to ablate a tumor near electrodes by electrolysis using a direct field with a constant current or voltage (DC field). Recently, reversible electroporated cells have been shown to be susceptible to electrolysis at relatively low doses. Reversible electroporation can also be combined with electrolysis for tissue ablation. Therefore, the objective of this study is to use electrolysis to remove the reversible electroporation area and thereby enlarge the ablation area in potato slices in vitro using a pulsed field with a bias DC field (constant voltage). We call this protocol electrolytic irreversible electroporation (E-IRE). The area over which the electrolytic effect induced a pH change was also measured. The results show that decreasing the pulse frequency using IRE alone is found to enlarge the ablation area. The ablation area generated by E-IRE is significantly larger than that generated by using IRE or EChT alone. The ablation area generated by E-IRE at 1 Hz is 109.5% larger than that generated by IRE, showing that the reversible electroporation region is transformed into an ablation region by electrolysis. The area with a pH change produced by E-IRE is larger than that produced by EChT alone. Decreasing the pulse frequency in the E-IRE protocol can further enlarge the ablation area. The results of this study are a preliminary indication that the E-IRE protocol can effectively enlarge the ablation area and enhance the efficacy of traditional IRE for use in ablating large tumors.
© 2022. The Author(s) under exclusive licence to Biomedical Engineering Society.

Entities:  

Keywords:  Electrolytic irreversible electroporation; Pulse frequency; Reversible electroporation; Tumor treatment

Year:  2022        PMID: 35852648     DOI: 10.1007/s10439-022-03017-9

Source DB:  PubMed          Journal:  Ann Biomed Eng        ISSN: 0090-6964            Impact factor:   4.219


  42 in total

1.  Tissue ablation with irreversible electroporation.

Authors:  R V Davalos; I L M Mir; B Rubinsky
Journal:  Ann Biomed Eng       Date:  2005-02       Impact factor: 3.934

2.  Changes in membrane structure induced by electroporation as revealed by rapid-freezing electron microscopy.

Authors:  D C Chang; T S Reese
Journal:  Biophys J       Date:  1990-07       Impact factor: 4.033

Review 3.  Experimental application of electrolysis in the treatment of liver and pancreatic tumours: principles, preclinical and clinical observations and future perspectives.

Authors:  G Gravante; S L Ong; M S Metcalfe; N Bhardwaj; G J Maddern; D M Lloyd; A R Dennison
Journal:  Surg Oncol       Date:  2010-01-04       Impact factor: 3.279

Review 4.  Nonthermal irreversible electroporation: fundamentals, applications, and challenges.

Authors:  Alexander Golberg; Martin L Yarmush
Journal:  IEEE Trans Biomed Eng       Date:  2013-01-09       Impact factor: 4.538

5.  Intrahepatic radiofrequency ablation versus electrochemical treatment in vivo.

Authors:  Ralf Czymek; Jan Nassrallah; Maximilian Gebhard; Andreas Schmidt; Stefan Limmer; Markus Kleemann; Hans-Peter Bruch; Philipp Hildebrand
Journal:  Surg Oncol       Date:  2010-11-27       Impact factor: 3.279

6.  The Feasibility of a Smart Surgical Probe for Verification of IRE Treatments Using Electrical Impedance Spectroscopy.

Authors:  Mohammad Bonakdar; Eduardo L Latouche; Roop L Mahajan; Rafael V Davalos
Journal:  IEEE Trans Biomed Eng       Date:  2015-06-04       Impact factor: 4.538

7.  Electrochemical red-ox therapy of prostate cancer in nude mice.

Authors:  Fabio L Cury; Bimal Bhindi; Joice Rocha; Eleonora Scarlata; Katia El Jurdi; Michel Ladouceur; Stéphane Beauregard; Ashok K Vijh; Yosh Taguchi; Simone Chevalier
Journal:  Bioelectrochemistry       Date:  2014-12-19       Impact factor: 5.373

8.  Irreversible electroporation for unresectable hepatocellular carcinoma: initial experience and review of safety and outcomes.

Authors:  W Cheung; H Kavnoudias; S Roberts; B Szkandera; W Kemp; K R Thomson
Journal:  Technol Cancer Res Treat       Date:  2013-01-25

9.  Electrochemical treatment: An investigation of dose-response relationships using an isolated liver perfusion model.

Authors:  Ralf Czymek; Dorothea Dinter; Stephan Löffler; Maximilian Gebhard; Tilman Laubert; Andreas Lubienski; Hans-Peter Bruch; Andreas Schmidt
Journal:  Saudi J Gastroenterol       Date:  2011 Sep-Oct       Impact factor: 2.485

10.  Tumor ablation with irreversible electroporation.

Authors:  Bassim Al-Sakere; Franck André; Claire Bernat; Elisabeth Connault; Paule Opolon; Rafael V Davalos; Boris Rubinsky; Lluis M Mir
Journal:  PLoS One       Date:  2007-11-07       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.